Literature DB >> 12405292

Expression profiling and interferon-beta regulation of liver metastases in colorectal cancer cells.

Regis Zimmer1, Peter Thomas.   

Abstract

Liver metastasis is the major cause of death among colorectal cancer patients. Many gene products have been associated with the colon cancer cells' ability to metastasize to the liver, including carcinoembryonic antigen (CEA) and mucins. In this study we examined changes in expression of 384 genes in a model of human colorectal cancer metastasis in nude mice. Using DNA microarrays, we compared expression between MIP-101 cells, a poorly metastatic human colon cancer cell line, with an interferon-beta (IFN-beta) resistant subline of MIP-101 (beta-MIP) that is metastatic to the liver. Treatment of beta-MIP cells with increasing concentrations of IFN-beta caused a reversion to the non-metastatic phenotype. The array data showed down-regulation of genes involved in apoptosis in beta-MIP cells and their return to the MIP-101 pattern upon IFN-beta treatment. Cluster analysis also showed involvement of genes belonging to cell cycle, angiogenesis and invasion pathways. Selected genes were chosen to validate the microarray data by semi-quantitative RT-PCR. Association between gene expression pattern and metastatic phenotype was verified by intra-splenic injection in nude mice. The number of genes examined in this study was small, but carefully selected. Significant changes associated with cell growth and survival were observed, which gave the metastatic cells an advantage to grow in the liver. This information may help identifying new markers for colorectal cancer prognosis as well as aid the development of new therapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12405292     DOI: 10.1023/a:1020325327461

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  35 in total

1.  Caspases and mitochondria in c-Myc-induced apoptosis: identification of ATM as a new target of caspases.

Authors:  A Hotti; K Järvinen; P Siivola; E Hölttä
Journal:  Oncogene       Date:  2000-05-04       Impact factor: 9.867

2.  Antisense oligodeoxynucleotide of glyceraldehyde-3-phosphate dehydrogenase gene inhibits cell proliferation and induces apoptosis in human cervical carcinoma cell lines.

Authors:  J W Kim; T E Kim; Y K Kim; Y W Kim; S J Kim; J M Lee; I K Kim; S E Namkoong
Journal:  Antisense Nucleic Acid Drug Dev       Date:  1999-12

Review 3.  Angiogenesis and cancer metastasis.

Authors:  I J Fidler
Journal:  Cancer J       Date:  2000-04       Impact factor: 3.360

4.  Expression of insulin-like growth factor-1 receptor in human colorectal cancer.

Authors:  A Hakam; T J Yeatman; L Lu; L Mora; G Marcet; S V Nicosia; R C Karl; D Coppola
Journal:  Hum Pathol       Date:  1999-10       Impact factor: 3.466

5.  Over-expression of GAPDH induces apoptosis in COS-7 cells transfected with cloned GAPDH cDNAs.

Authors:  H Tajima; K Tsuchiya; M Yamada; K Kondo; N Katsube; R Ishitani
Journal:  Neuroreport       Date:  1999-07-13       Impact factor: 1.837

Review 6.  Therapy of cancer metastasis by activation of the inducible nitric oxide synthase.

Authors:  K Xie; I J Fidler
Journal:  Cancer Metastasis Rev       Date:  1998-03       Impact factor: 9.264

7.  Up-regulation of inducible nitric oxide synthase and production of nitric oxide by the Swarm rat and human chondrosarcoma.

Authors:  P E Di Cesare; C S Carlson; M Attur; A A Kale; S B Abramson; C Della Valle; G Steiner; A R Amin
Journal:  J Orthop Res       Date:  1998-11       Impact factor: 3.494

8.  The role of mucin in colon-cancer metastasis.

Authors:  B Schwartz; R S Bresalier; Y S Kim
Journal:  Int J Cancer       Date:  1992-08-19       Impact factor: 7.396

9.  Abrogation of tumorigenicity and metastasis of murine and human tumor cells by transfection with the murine IFN-beta gene: possible role of nitric oxide.

Authors:  K Xie; D Bielenberg; S Huang; L Xu; T Salas; S H Juang; Z Dong; I J Fidler
Journal:  Clin Cancer Res       Date:  1997-12       Impact factor: 12.531

10.  Reduced expression of laminin alpha 3 and alpha 5 chains in non-small cell lung cancers.

Authors:  T Akashi; E Ito; Y Eishi; M Koike; K Nakamura; R E Burgeson
Journal:  Jpn J Cancer Res       Date:  2001-03
View more
  6 in total

Review 1.  Carcinoembryonic antigen (CEA) and its receptor hnRNP M are mediators of metastasis and the inflammatory response in the liver.

Authors:  Peter Thomas; R Armour Forse; Olga Bajenova
Journal:  Clin Exp Metastasis       Date:  2011-09-07       Impact factor: 5.150

2.  The addition of tumor necrosis factor plus beta interferon induces a novel synergistic antiviral state against poxviruses in primary human fibroblasts.

Authors:  Eric Bartee; Mohamed R Mohamed; M Cecilia Lopez; Henry V Baker; Grant McFadden
Journal:  J Virol       Date:  2008-10-29       Impact factor: 5.103

Review 3.  Augmentation of effects of interferon-stimulated genes by reversal of epigenetic silencing: potential application to melanoma.

Authors:  Ernest C Borden
Journal:  Cytokine Growth Factor Rev       Date:  2007-08-06       Impact factor: 7.638

4.  Interferon-beta inhibits liver metastases from murine colon 26 carcinoma and its highly metastatic variant.

Authors:  Shigechika Kohashi; Yuji Sato; Tsuyoshi Fukushima; Hiroki Shomura; Takahiro Oshima; Sun Bairun; Masao Kondo; Yoshie Une; Jun Nishihira; Satoru Todo
Journal:  Surg Today       Date:  2007-05-28       Impact factor: 2.549

5.  Gene expression profiling of the cellular transcriptional network regulated by alpha/beta interferon and its partial attenuation by the hepatitis C virus nonstructural 5A protein.

Authors:  Gary K Geiss; Victoria S Carter; Yupeng He; Bartlomiej K Kwieciszewski; Ted Holzman; Marcus J Korth; Catherine A Lazaro; Nelson Fausto; Roger E Bumgarner; Michael G Katze
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

Review 6.  ISG15 in the tumorigenesis and treatment of cancer: An emerging role in malignancies of the digestive system.

Authors:  Chaohui Zuo; Xinyi Sheng; Min Ma; Man Xia; Linda Ouyang
Journal:  Oncotarget       Date:  2016-11-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.